Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	287.41	68.07	17.57
Graham Fair Price	4.66	7.06	6.75
PEG	525.29	1.05	0.17
Price/Book	39.48	0.64	0.46
Price/Cash Flow	inf	0.00	23.95
Prices/Earnings	36.15	3.38	2.48
Price/Sales	3.87	3.18	3.06
Price/FCF	inf	0.00	23.95
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-61.64	0.07	0.18
ROA	7.30	< 0.005	< 0.005
ROE	0.05	0.05	2.44
ROIC	0.02	< 0.005	-82.36
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.55	-0.27	102.60
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.51	-0.47	8.54
EPS QOQ	0.15	0.03	-78.23
FCF QOQ	0.52	-1.00	93.77
Revenue QOQ	0.01	0.39	3319.32
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	9.71	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.64	0.70	10.22
Quick Ratio	32.85	-32.51	-1.04
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.62	6.84	3.40
Cash	7.13	-7.74	8.61
Capex	0.00	0.00	0.00
Free Cash Flow	0.13	0.00	inf
Revenue	0.99	1.37	38.86
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	32.37	37.20	14.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.23	37.24	612.07
Naive Interpretation	Member

06 - Financial Health · Bad

Rating